BioMarin Pharmaceutical Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
120.48
|
|
Average Rating
|
4.43
|
|
# Strong Buys
|
13
|
|
# Buys
|
7
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.01
|
-0.04
|
-0.03
|
-300.00%
|
|
2022-06-30
|
0.11
|
0.15
|
0.04
|
36.36%
|
|
2022-03-31
|
0.17
|
0.63
|
0.46
|
270.59%
|
|
2021-12-31
|
-0.32
|
-0.32
|
0.00
|
0.00%
|
|
2021-09-30
|
-0.25
|
-0.20
|
0.05
|
20.00%
|
|
2021-06-30
|
-0.11
|
0.07
|
0.18
|
163.64%
|
|
2021-03-31
|
-0.07
|
0.09
|
0.16
|
228.57%
|
|
2020-12-31
|
-0.19
|
0.12
|
0.31
|
163.16%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.74
|
|
2021-12-31
|
-0.36
|
|
2020-12-31
|
4.41
|
|
2019-12-31
|
-0.15
|
|
2018-12-31
|
-0.43
|
|
2017-12-31
|
-0.66
|
|
2016-12-31
|
-3.93
|
|
2015-12-31
|
-1.12
|
|
2014-12-31
|
-0.97
|
|
2013-12-31
|
-1.27
|
|
2012-12-31
|
-0.95
|
|
2011-12-31
|
-0.46
|
|
2010-12-31
|
1.69
|
|
2009-12-31
|
-0.01
|
|
2008-12-31
|
0.28
|
|
2007-12-31
|
-0.16
|
|
2006-12-31
|
-0.34
|
|
2005-12-31
|
-1.09
|
|
2004-12-31
|
-1.22
|
|
2003-12-31
|
-1.22
|
|
2002-12-31
|
-1.46
|
|
2001-12-31
|
-1.16
|
|
2000-12-31
|
-1.04
|
|
1999-12-31
|
-0.50
|